Insulin receptor kinase defects as a possible cause of cellular insulin resistance
- PMID: 2820811
Insulin receptor kinase defects as a possible cause of cellular insulin resistance
Abstract
The insulin receptor contains in its beta-subunit a tyrosine (-) specific protein kinase. It is believed that transmission of an insulin signal across the plasma membrane of target cells of insulin action occurs through activation of this kinase, autophosphorylation of the insulin receptor beta-subunit and subsequent phosphorylation of other cellular substrates. We studied the insulin receptor kinase in a number of insulin resistant cell systems in order to elucidate if defects of this kinase are a possible cause of cellular insulin resistance. Three different patterns of kinase abnormalities were found, in different insulin resistant cells: 1. In an insulin resistance melanoma cell line a reduced receptor kinase autophosphorylation was found apparently due to a defect of the tyrosine autophosphorylation sites of this receptor; 2. Catecholamine and phorbol ester induced insulin resistance of isolated rat fat cells as well as human fat cells was associated with a decreased activity of the insulin receptor tyrosine kinase which was apparently due to a modulation of the ATP binding site of the insulin receptor tyrosine kinase; 3. The receptor kinase isolated from the skeletal muscle of diabetic Zucker rats (fa/fa) was found to be insulin insensitive with no major alteration of maximal responsiveness. These results suggested that different forms of kinase defects exist which can contribute to the pathogenesis of cellular insulin resistance. Based on these data studies in skeletal muscle from type II diabetic patients were started. Results from five patients so far suggest that, here as well, an abnormality of the insulin receptor kinase exists which might be involved in the pathogenesis of insulin resistance in type II diabetes.
Similar articles
-
Effect of phosphotyrosyl-IRS-1 level and insulin receptor tyrosine kinase activity on insulin-stimulated phosphatidylinositol 3, MAP, and S6 kinase activities.J Cell Physiol. 1995 Apr;163(1):9-18. doi: 10.1002/jcp.1041630103. J Cell Physiol. 1995. PMID: 7896903
-
Defect in skeletal muscle phosphatidylinositol-3-kinase in obese insulin-resistant mice.J Clin Invest. 1993 Apr;91(4):1358-66. doi: 10.1172/JCI116337. J Clin Invest. 1993. PMID: 8386184 Free PMC article.
-
Abnormal insulin receptor tyrosine kinase activity in kidney basolateral membranes from non-insulin-dependent diabetic rats.J Lab Clin Med. 1990 Jun;115(6):704-11. J Lab Clin Med. 1990. PMID: 2164078
-
Insulin receptor binding and action in human adipocytes. A critical approach to methods, correlations with receptor binding to other cell types, and relations between insulin binding and action.Dan Med Bull. 1991 Jun;38(3):252-70. Dan Med Bull. 1991. PMID: 1868754 Review.
-
Cellular mechanism of metformin action.Diabete Metab. 1991 May;17(1 Pt 2):146-9. Diabete Metab. 1991. PMID: 1936468 Review.
Cited by
-
Orally active insulin mimics: where do we stand now?J Biosci. 2001 Sep;26(3):383-90. doi: 10.1007/BF02703748. J Biosci. 2001. PMID: 11568484 Review.
-
Regulation of human insulin receptor RNA splicing in vivo.Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1465-9. doi: 10.1073/pnas.91.4.1465. Proc Natl Acad Sci U S A. 1994. PMID: 8108432 Free PMC article.
-
Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: candidates for a signal transmitter defect causing insulin resistance of the skeletal muscle.Diabetologia. 1993 Mar;36(3):176-82. doi: 10.1007/BF00399946. Diabetologia. 1993. PMID: 8385036 Review.
-
Decreased skeletal muscle phosphotyrosine phosphatase (PTPase) activity towards insulin receptors in insulin-resistant Zucker rats measured by delayed Europium fluorescence.Diabetologia. 1996 Feb;39(2):142-8. doi: 10.1007/BF00403956. Diabetologia. 1996. PMID: 8635665
-
Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus.Diabetologia. 1991 Apr;34(4):239-45. doi: 10.1007/BF00405082. Diabetologia. 1991. PMID: 1906024